Aiming for Remission in Rheumatoid Arthritis: Clinical and Radiographic Outcomes from a Randomized Controlled Strategy Trial Investigating the Added Value of Ultrasonography in a Treat-to-Target Regimen

被引：0

作者：

Haavardsholm, Espen A. ^{[1
]}

Aga, Anna-Birgitte ^{[1
]}

Olsen, Inge C. ^{[1
]}

Hammer, Hilde B. ^{[2
]}

Uhlig, Till ^{[2
]}

Fremstad, Hallvard ^{[3
]}

Madland, Tor Magne ^{[4
]}

Lexberg, Ase S. ^{[5
]}

Haukeland, Hilde ^{[6
]}

Rodevand, Erik ^{[7
]}

Hoili, Christian ^{[8
]}

Stray, Hilde ^{[9
]}

Bendvold, Anne Noraas ^{[10
]}

Hansen, Inger Johanne Widding ^{[11
]}

Bakland, Gunnstein ^{[12
,13
]}

Nordberg, Lena B. ^{[1
]}

Lillegraven, Siri ^{[1
]}

van der Heijde, Desiree ^{[1
,14
]}

Kvien, Tore K. ^{[1
]}

机构：

[1] Diakonhjemmet Hosp, Dept Rheumatol, Oslo, Norway

[2] Diakonhjemmet Hosp, Oslo, Norway

[3] Helse More & Romsdal HF, Alesund Hosp, Dept Rheumatol, Alesund, Norway

[4] Haukeland Hosp, Dept Rheumatol, N-5021 Bergen, Norway

[5] Vestre Viken Hosp, Dept Rheumatol, Drammen, Norway

[6] Martina Hansens Hosp, Dept Rheumatol, Baerum, Norway

[7] St Olavs Hosp, Dept Rheumatol, Trondheim, Norway

[8] Hosp Ostfold HF, Dept Rheumatol, Moss, Norway

[9] Haugesund Rheumatism Hosp, Haugesund, Norway

[10] Rheumatol Clin Dovland Bendvold, Kristiansand, Norway

[11] Sorlandet Hosp, Dept Rheumatol, Kristiansand, Norway

[12] Univ Hosp Northern Norway, Dept Rheumatol, Tromso, Norway

[13] Univ Hosp North Norway, Inst Clin Med, Tromso, Norway

[14] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands

来源：

ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

10L

引用

页数：5

共 50 条

[31] A Cluster-Randomized Trial of a Behavioral Intervention to Incorporate a Treat-to-Target Approach in the Clinical Care of Rheumatoid Arthritis Patients in the United States
Harrold, Leslie
Reed, George W.
Harrington, J. Timothy
Barr, Christine J.
Saunders, Katherine C.
Gibofsky, Allan
Ruderman, Eric M.
Haselkorn, Tmirah
Greenberg, Jeffrey D.
John, Ani
Kremer, Joel M.
ARTHRITIS & RHEUMATOLOGY, 2015, 67
[32] Adherence to a Treat-To-Target Strategy is Key to Attainment of Sustained Remission in Rheumatoid Arthritis: Data from the Real-world Practice BIODAM Cohort
Homik, Joanne
Larche, Maggie
Boire, Gilles
Barnabe, Cheryl
Rahman, Proton
Hitchon, Carol
Hutchings, Edna
Dadashova, Rana
Paschke, Joel
Maksymowych, Walter
JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1223 - 1224
[33] Long-term clinical, functional, and cost outcomes for early rheumatoid arthritis patients who did or did not achieve early remission in a real-world treat-to-target strategy
ten Klooster, Peter M.
Voshaar, Martijn A. H. Oude
Fakhouri, Walid
de la Torre, Inmaculada
Nicolay, Claudia
van de Laar, Mart A. F. J.
CLINICAL RHEUMATOLOGY, 2019, 38 (10) : 2727 - 2736
[34] EFFECT OF TREAT-TO-TARGET STRATEGY ON DISEASE ACTIVITY AND RADIOLOGIC OUTCOMES IN RHEUMATOID ARTHRITIS: RESULTS FROM A 9-YEAR CHINESE COHORT
Ji, Lanlan
Xie, Wenhui
Li Guangtao
Zhang, Zhuoli
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 311 - 311
[35] Long-term clinical, functional, and cost outcomes for early rheumatoid arthritis patients who did or did not achieve early remission in a real-world treat-to-target strategy
Peter M. ten Klooster
Martijn A. H. Oude Voshaar
Walid Fakhouri
Inmaculada de la Torre
Claudia Nicolay
Mart A. F. J. van de Laar
Clinical Rheumatology, 2019, 38 : 2727 - 2736
[36] Impact of a magnetic resonance imaging-guided treat-to-target strategy on disease activity and progression in patients with rheumatoid arthritis (the IMAGINE-RA trial): study protocol for a randomized controlled trial
Moller-Bisgaard, Signe
Horslev-Petersen, Kim
Ejbjerg, Bo Jannik
Boesen, Mikael
Hetland, Merete Lund
Christensen, Robin
Moller, Jakob
Krogh, Niels Steen
Stengaard-Pedersen, Kristian
Ostergaard, Mikkel
TRIALS, 2015, 16
[37] Impact of a magnetic resonance imaging-guided treat-to-target strategy on disease activity and progression in patients with rheumatoid arthritis (the IMAGINE-RA trial): study protocol for a randomized controlled trial
Signe Møller-Bisgaard
Kim Hørslev-Petersen
Bo Jannik Ejbjerg
Mikael Boesen
Merete Lund Hetland
Robin Christensen
Jakob Møller
Niels Steen Krogh
Kristian Stengaard-Pedersen
Mikkel Østergaard
Trials, 16
[38] ASSOCIATION OF CLINICAL REMISSION AND NORMALIZED PATIENT REPORTED OUTCOMES: A VALIDATION OF TREAT-TO-TARGET FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS USING POOLED DATA FROM 3 PHASE III GOLIMUMAB CLINICAL TRIALS
Keystone, E.
Fleischmann, R.
Han, C.
Smolen, J. S.
Emery, P.
Genovese, M.
Gathany, T.
Doyle, M.
Hsia, E.
VALUE IN HEALTH, 2011, 14 (03) : A133 - A133
[39] TREAT-TO-TARGET DOSE REDUCTION AND WITHDRAWAL STRATEGY OF TNF INHIBITORS IN PSORIATIC ARTHRITIS AND AXIAL SPONDYLOARTHRITIS: A RANDOMIZED CONTROLLED NON-INFERIORITY TRIAL
Michielsens, C.
den Broeder, N.
van den Hoogen, F.
Mahler, E.
Teerenstra, S.
van der Heijde, D.
Verhoef, L. M.
den Broeder, A.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 172 - 173
[40] GENERAL APPLICABILITY OF A NEW TREAT-TO-TARGET TREATMENT STRATEGY IN DUTCH PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: RESULTS FROM THE DREAM REMISSION INDUCTION COHORT II
Steunebrink, L. M. M.
Vonkeman, H. E.
Ten Klooster, P. M.
Kuper, H. H.
van der Bijl, A. E.
van Riel, P. L.
van de Laar, M. A.
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 237 - 237

← 1 2 3 4 5 →